Pharmaceutical Services and global health governance in times of Covid-19

Datos Bibliográficos

ID5333715
AutoresAlane Andrelino Ribeiro (0000-0003-0233-9465, Universidade de Brasília), Luciani Martins Ricardi (0000-0002-7500-0465, Ministério da Saúde (MS), Brasil), Margareth Alves Pontes (0000-0002-0726-7475, Universidade de Brasília), Silvana Nair Leite (0000-0002-5258-9684, Universidade Federal de Santa Catarina)
Año2022
Volumen46
Número133
Páginas501-517
Fecha de publicación2022-04-01
Peer ReviewedSí
Open AccessSí
TipoARTICLE
RevistaSaúde em Debate (JOURNAL)
Identificadores de la revistaISSN: 0103-1104 • E-ISSN: 2358-2898
EditorialFapUNIFESP (SciELO) (PUBLISHER)
DOI10.1590/0103-1104202213318i
OpenAlexW4283166228
IdiomaEN
Referencias citadas13

This essay addresses how and at what levels Pharmaceutical Services is affected by the dynamics of global health governance, and how it correlates with geopolitical and socioeconomic aspects. It attempts to go beyond access to medicines and health products, as well as to address the rational use of medicines, the impact in antimicrobial resistance and in people's health. Furthermore, it debates how Pharmaceutical Services can be seen in this context

Business · Context (archaeology) · Coronavirus disease 2019 (COVID-19) · Corporate governance · Environmental health · Geography · Geopolitics · Global health · Health care · Health services · Infectious disease (medical specialty) · Political science · Politics · Public relations · Socioeconomic status · Global Public Health Policies and Epidemiology · Global Security and Public Health · Law · Medicine · Pharmaceutical Economics and Policy